InsidersTradesSigma
Follow the Gabelli Healthcare & WellnessRx Trust share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Finance & Banking sector, Gabelli Healthcare & WellnessRx Trust has recorded 84 public disclosures. Market capitalisation: €148.8m. The latest transaction was filed on 28 August 2026 (Acquisition). Among the most active insiders: Saba Capital Management, L.P.. The full history is free.
84
Insider Decl.
n/a
Thresholds
€34m
74 ops.
Buy Volume
€3m
4 ops.
Sell Volume
45Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
Declarations84 total
4,340 shares@ US$10.05Common StockSEC:0001510281-26-000282:0
Canonical exit: 25 Nov 2026 (T+90)
7,087 shares@ US$10.130.048% mcap1.6% of flowCommon StockSEC:0001510281-26-000275:0
Canonical exit: 19 Nov 2026 (T+90)
24,102 shares@ US$10.130.17% mcap5.5% of flowCommon StockSEC:0001510281-26-000273:0
Canonical exit: 17 Nov 2026 (T+90)
1,203 shares@ US$9.860.0080% mcap0.3% of flowCommon StockSEC:0001510281-26-000268:0
Canonical exit: 12 Nov 2026 (T+90)
200 shares@ US$9.930.0013% mcap0.0% of flowCommon StockSEC:0001510281-26-000266:0
Canonical exit: 9 Nov 2026 (T+90)
3,800 shares@ US$9.580.1% of flowCommon Shares, Par Value $0.001SEC:0001185533-26-000006:0
Canonical exit: 12 Apr 2026 (T+90)
990 shares@ US$9.580.0% of flowCommon Shares, Par Value $0.001SEC:0001185533-26-000004:0
Canonical exit: 8 Apr 2026 (T+90)
500,000 shares@ US$10.008.9% of flowSeries E Cumulative Preferred SharesSEC:0001185533-26-000001:0
Canonical exit: 26 Mar 2026 (T+90)
100,000 shares@ US$10.001.9% of flowSeries G Cumulative Preferred SharesSEC:0001185533-25-000016:0
Canonical exit: 26 Mar 2026 (T+90)
11,312 shares@ US$9.372.5% of flowCommon StockSEC:0001510281-25-000628:0
Canonical exit: 16 Mar 2026 (T+90)
2,500 shares@ US$9.68770.0% of flowCommon Shares, Par Value $0.001SEC:0001185533-25-000010:0
Canonical exit: 3 Mar 2026 (T+90)
2,000 shares@ US$9.119860.1% of flowCommon Shares, Par Value $0.001SEC:0001247238-25-000008:0
14,451 shares@ US$9.623.5% of flowCommon StockSEC:0001510281-25-000595:0
Canonical exit: 23 Feb 2026 (T+90)
1,800,000 shares@ US$10.179137.0% of flowSeries G Cumulative Preferred SharesSEC:0001185533-25-000007:0
Canonical exit: 28 Jan 2026 (T+90)
20,808 shares@ US$9.284.9% of flowCommon StockSEC:0001510281-25-000529:0
Canonical exit: 21 Jan 2026 (T+90)
6,122 shares@ US$9.291.5% of flowCommon StockSEC:0001510281-25-000523:0
Canonical exit: 19 Jan 2026 (T+90)
3,520 shares@ US$9.180.9% of flowCommon StockSEC:0001510281-25-000517:0
Canonical exit: 14 Jan 2026 (T+90)
6,147 shares@ US$9.431.6% of flowCommon StockSEC:0001510281-25-000482:0
Canonical exit: 10 Dec 2025 (T+90)
11,330 shares@ US$9.483.0% of flowCommon StockSEC:0001510281-25-000432:0
Canonical exit: 23 Nov 2025 (T+90)
19,101 shares@ US$9.435.0% of flowCommon StockSEC:0001510281-25-000429:0
Canonical exit: 19 Nov 2025 (T+90)
12,924 shares@ US$9.383.7% of flowCommon StockSEC:0001510281-25-000388:0
Canonical exit: 13 Oct 2025 (T+90)
6,080 shares@ US$9.351.7% of flowCommon StockSEC:0001510281-25-000384:0
Canonical exit: 12 Oct 2025 (T+90)
3,952 shares@ US$9.481.1% of flowCommon StockSEC:0001510281-25-000381:0
Canonical exit: 8 Oct 2025 (T+90)
10,000 shares@ US$10.000.3% of flowSeries G Cumulative Preferred SharesSEC:0001271163-25-000023:0
830,000 shares@ US$10.0026.4% of flowSeries E Cumulative Preferred SharesSEC:0001271163-25-000022:0
25 of 84 declarations
关于 Gabelli Healthcare & WellnessRx Trust
Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) 是一只在美国上市的封闭式基金，专注于医疗保健和健康领域的投资机会。对于国际投资者而言，GRX并非一家运营中的医疗保健公司，而是一家由GAMCO Investors子公司Gabelli Funds, LLC积极管理的投资公司。其核心任务是实现长期资本增值，投资组合通常与医疗保健服务、制药、医疗产品、设备以及更广泛的健康相关业务的结构性主题挂钩。（[gabelli.com](https://gabelli.com/wp-content/uploads/2026/01/closedEnd_FactSheets-4Q-2025_GRX.pdf)） 该基金成立于2007年，在多个市场机制下拥有重要的运营历史，包括医疗保健轮动期、利率波动期以及对防御性增长资产情绪转变的时期。它位于美国纽约州Rye，隶属于Gabelli管理平台。对于全球投资者而言，重要的是GRX在纽约证券交易所交易，根据美国市场规则提供交易所上市的流动性和透明度。（[stockanalysis.com](https://stockanalysis.com/stocks/grx/company/?utm_source=openai)） GRX的投资目标直截了当：通过投资医疗保健和健康行业提供的机会，寻求长期资本增长。这种主题性关注使该基金能够受益于人口老龄化、治疗创新、医疗保健支出增加以及对预防性导向和生活质量产品与服务的需求等长期驱动因素。作为一只封闭式基金，其市场价格可能偏离资产净值，因此投资者必须评估标的投资组合的表现以及上市工具的溢价/折价动态。2024年年度报告显示，该年度资产净值略有下降，而公开交易的股价表现更好，这突显了这种区别。（[gabelli.com](https://gabelli.com/wp-content/uploads/2025/04/GRXAnnualReport.pdf)） 从竞争角度来看，GRX处于一个专业利基市场：一只专注于医疗保健的封闭式基金，拥有成熟的Gabelli品牌和积极的、由证券选择驱动的方法。其吸引力不仅在于行业敞口，还在于其分派政策。自2012年6月以来，该基金已按季度向其普通股支付分派，并在2026年2月宣布第一季度现金分派为每股0.17美元，高于此前的0.15美元水平。这对于以收入为导向的投资者很重要，尤其是在欧洲，收益的一致性和分派纪律通常是投资组合构建的核心。（[gabelli.com](https://gabelli.com/wp-content/uploads/2025/04/GRXAnnualReport.pdf)） 最近的披露也再次证实，GRX仍然是一个活跃的、向SEC报告的上市工具，而非静态的遗留信托。其2026年的备案文件和基金通讯表明，Gabelli Funds持续进行投资组合管理，同时在2026年2月分派公告时，报告的总净资产基础约为233亿美元。实际上，GRX最好被视为一只专注于美国医疗保健的纽约证券交易所上市利基基金，具有长期增长任务、以分派为导向的特征，并对医疗保健基本面和封闭式基金的市场定价均敏感。（[gabelli.com](https://gabelli.com/wp-content/uploads/2026/02/03-26-div_GRX-4.pdf)）
